Patent · US Active

Therapeutic heterocyclic compounds

US11098027B2 · kind B2 · utility

0Cited by
20References
46Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 3, 2019
Grant dateAug 24, 2021
Priority date—
Expiry dateAug 10, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K31/519
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds having the following Formula (I), or a pharmaceutically acceptable salt thereof, and methods of their use and preparation are disclosed:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.